Clinical Trial Update: Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy and tolerability of a benzalkonium chloride-free (BAK-free) formulation of latanoprost in primary open-angle glaucoma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Latanoprost (BAK-free formulation) (Latanoprost)

Snippet

Sponsor: Laboratorios Poen | Conditions: Primary Open-angle Glaucoma | Phase 4 | Status: COMPLETED